Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.280
-0.110 (-4.60%)
At close: May 15, 2026, 4:00 PM EDT
2.320
+0.040 (1.75%)
After-hours: May 15, 2026, 7:51 PM EDT
Acumen Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
61
Market Cap
164.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Heron Therapeutics | 150.71M |
| Protalix BioTherapeutics | 76.38M |
| Black Diamond Therapeutics | 70.00M |
| ProQR Therapeutics | 15.73M |
| Equillium | 4.39M |
ABOS News
- 1 day ago - Acumen Pharmaceuticals Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 3 days ago - Acumen Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 3 days ago - Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire
- 8 days ago - Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference - GlobeNewsWire
- 10 days ago - Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026 - GlobeNewsWire
- 7 weeks ago - Acumen files to sell 10.83M shares of common stock for holders - TheFly
- 7 weeks ago - Options Volatility and Implied Earnings Moves Today, March 26, 2026 - TipRanks
- 7 weeks ago - Acumen Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts